Skip to main content
. 2016 Jan 19;6(1):e717. doi: 10.1038/tp.2015.213

Table 1. The demographic of schizophrenia patients and the non-psychiatric controls in the peripheral blood cohort and the postmortem brain cohort.

Variable Peripheral blood cohort
  Schizophrenia (N=48) Controls (N=37)
  N (%) N (%)
Gender
 Female 23 (47.9) 23 (62.2)
 Male 25 (52.1) 14 (37.8)
 
  Mean (s.d.) Mean (s.d.)
Education (years)a 11.3 (2.9) 17.1 (3.5)
Age 40.2 (10.7) 38.0 (10.8)
Age at onset 23.6 (7.0)
Duration of illness 16.8 (10.5)
Chlorpromazine equivalent (mg daily) 453.3 (276.1)
  Postmortem brain cohort
  Schizophrenia (N=25) Controls (N=27)
  N (%) N (%)
Gender
 Female 4 (16.0) 5 (19.5)
 Male 21 (84.0) 22 (81.5)
 
Suicideb
 Yes 9 (36.0) 0 (0.0)
 No 16 (64.0) 27 (100.0)
 
  Mean (s.d.) Mean (s.d.)
Age 43.4 (18.3) 43.3 (18.1)
Age at onset 25.6 (9.8)
Duration of illness 17.5 (15.4)
PMI (h) 40.4 (12.4) 41.4 (15.2)
Brain pH 6.3 (0.2) 6.3 (0.2)
RIN 8.3 (0.7) 8.5 (0.5)
Chlorpromazine equivalent (mg daily) 651.8 (628.5)

Abbreviations: PMI, postmortem interval; RIN, RNA integrity numbers.

a

P<0.001 based on t-test.

b

P<0.0001 based on Fisher's exact test.